Inactive Ingredient Search for Approved Drug Products

Search Names Beginning with I

Inactive Ingredient Route Dosage Form CAS Number UNII Maximum Potency per unit dose Maximum Daily Exposure (MDE) Record Updated
ICODEXTRIN ORAL GRANULE, FOR SOLUTION 337376155 2NX48Z0A9G 22mg/5ml
ICODEXTRIN ORAL POWDER, FOR SOLUTION 337376155 2NX48Z0A9G 12.5mg/5ml
ICODEXTRIN ORAL SOLUTION 337376155 2NX48Z0A9G 20mg/5ml
ICODEXTRIN ORAL TABLET 337376155 2NX48Z0A9G 8mg
ICODEXTRIN ORAL TABLET, COATED 337376155 2NX48Z0A9G 10mg
ICODEXTRIN ORAL TABLET, DELAYED RELEASE 337376155 2NX48Z0A9G 9.25mg
ICODEXTRIN ORAL TABLET, EXTENDED RELEASE 337376155 2NX48Z0A9G 6mg
ICODEXTRIN TOPICAL CREAM 337376155 2NX48Z0A9G 0.03%w/w
ICODEXTRIN TOPICAL LOTION 337376155 2NX48Z0A9G NA
ICODEXTRIN TOPICAL SHAMPOO 337376155 2NX48Z0A9G 5%w/w
IMIDUREA TOPICAL CREAM 39236469 M629807ATL 0.4%w/w
IMIDUREA TOPICAL LOTION 39236469 M629807ATL 0.4%w/w
IMIDUREA TOPICAL SHAMPOO 39236469 M629807ATL 0.4%w/w
INDIGOTINDISULFONATE SODIUM ORAL CAPSULE 860220 D3741U8K7L 0.68mg
INDIGOTINDISULFONATE SODIUM ORAL TABLET 860220 D3741U8K7L 2.87mg
INDIGOTINDISULFONATE SODIUM ORAL TABLET, EXTENDED RELEASE 860220 D3741U8K7L 0.04mg
INK BLACK 2271 ORAL CAPSULE NA NA
INK BLACK A-10464 ORAL TABLET, EXTENDED RELEASE NA NA
INK BLACK A-10527 ORAL TABLET, EXTENDED RELEASE NA 0.19mg
INK BLACK FGE-1386 ORAL CAPSULE NA NA
INK BLACK SW-9007 ORAL TABLET NA 0.09mg
INK BLACK SW-9007 ORAL TABLET, FILM COATED NA 0.09mg
INK BLACK SW-9008 NASAL POWDER NA NA
INK BLACK SW-9008 ORAL CAPSULE NA 1mg
INK BLACK SW-9008 ORAL CAPSULE, COATED NA NA
INK BLACK SW-9008 ORAL CAPSULE, DELAYED RELEASE NA 1mg
INK BLACK SW-9008 ORAL CAPSULE, EXTENDED RELEASE NA 1mg Y
INK BLACK SW-9009 ORAL CAPSULE NA NA
INK BLACK SW-9009 ORAL CAPSULE, EXTENDED RELEASE NA NA
INK BLUE TEK PRINT SB-6029 ORAL CAPSULE NA NA
INK BLUE TEK PRINT SB-6029 ORAL TABLET, EXTENDED RELEASE NA 0.2mg
INK BLUE TEKPRINT SB-6018 ORAL CAPSULE NA 63.31mg
INK BLUE TEKPRINT SB-6018 ORAL CAPSULE, EXTENDED RELEASE NA 0.04mg
INK EDIBLE BLACK ORAL CAPSULE NA 0.25mg
INK EDIBLE BLACK ORAL TABLET NA 0.2mg
INK EDIBLE BLACK ORAL TABLET, COATED NA 0.4mg
INK EDIBLE BLACK ORAL TABLET, EXTENDED RELEASE NA 1mg
INK EDIBLE BLUE ORAL CAPSULE NA 1mg
INK EDIBLE BLUE ORAL TABLET NA NA
INK EDIBLE BLUE ORAL TABLET, COATED NA 0.04mg
INK EDIBLE BLUE ORAL TABLET, FILM COATED NA NA
INK EDIBLE BROWN ORAL TABLET, COATED NA 0.04mg
INK EDIBLE GRAY ORAL CAPSULE NA NA
INK EDIBLE RED ORAL TABLET NA 0.01mg
INK EDIBLE RED ORAL TABLET, COATED NA NA
INK EDIBLE RED ORAL TABLET, DELAYED RELEASE NA NA
INK EDIBLE WHITE ORAL CAPSULE NA NA
INK EDIBLE WHITE ORAL CAPSULE, EXTENDED RELEASE NA 0.04mg
INK EDIBLE WHITE ORAL TABLET, COATED NA NA
INK EDIBLE WHITE ORAL TABLET, EXTENDED RELEASE NA 0.19mg
INK EDIBLE WHITE ORAL TABLET, FILM COATED NA NA
INK FINE BLACK 2212 ORAL TABLET NA NA
INK FINE BLACK 2212 ORAL TABLET, EXTENDED RELEASE NA NA
INK RED A-8032 ORAL CAPSULE NA NA
INK RED A-8032 ORAL TABLET, COATED NA NA
INK S-1-7085 ORAL CAPSULE NA NA
INK WHITE A-8154 ORAL CAPSULE NA 0.8mg
INK WHITE A-8154 ORAL TABLET NA NA
INK WHITE SB-0007P ORAL CAPSULE NA 1mg
INK WHITE SW-0012 ORAL CAPSULE NA NA
INK WHITE SW-0012 ORAL CAPSULE, DELAYED RELEASE NA NA
INK WHITE SW-0012 ORAL TABLET NA 0.2mg
INVERT SUGAR ORAL CAPSULE 8013170 ED959S6ACY NA
INVERT SUGAR ORAL SOLUTION 8013170 ED959S6ACY 3.06ml/5ml
INVERT SUGAR ORAL SYRUP 8013170 ED959S6ACY 2560mg/5ml
IRON ORAL TABLET, EXTENDED RELEASE 7439896 E1UOL152H7 5mg
ISOBUTANE RECTAL AEROSOL, FOAM 75285 BXR49TP611 142mg
ISOBUTANE TOPICAL AEROSOL 75285 BXR49TP611 82.4%w/w
ISOBUTANE TOPICAL AEROSOL, FOAM 75285 BXR49TP611 18%w/w
ISOBUTANE TOPICAL AEROSOL, SPRAY 75285 BXR49TP611 82.39%w/w
ISOBUTANE TOPICAL SPRAY 75285 BXR49TP611 82.4%w/w
ISOLEUCINE INTRAVENOUS INJECTION 73325 04Y7590D77 0.9%w/v
ISOLEUCINE INTRAVENOUS INJECTION, SOLUTION 73325 04Y7590D77 0.21%w/v
ISOMALT ORAL CAPSULE 64519820 S870P55O2W 73mg
ISOMALT ORAL TABLET 64519820 S870P55O2W 630mg
ISOMALT ORAL TROCHE 64519820 S870P55O2W 1718.71mg
ISOMALT SUBLINGUAL POWDER 64519820 S870P55O2W 530mg Y
ISOPROPYL ALCOHOL TOPICAL GEL 67630 ND2M416302 20%w/w
ISOPROPYL ALCOHOL TOPICAL LOTION, AUGMENTED 67630 ND2M416302 30%w/w
ISOPROPYL ALCOHOL TOPICAL SOLUTION 67630 ND2M416302 40%w/v
ISOPROPYL ALCOHOL TOPICAL SPONGE 67630 ND2M416302 4%w/w
ISOPROPYL ALCOHOL TOPICAL SWAB 67630 ND2M416302 43.9%w/w
ISOPROPYL ISOSTEARATE TOPICAL CREAM 68171335 C67IXB9Y7T 3%w/w
ISOPROPYL MYRISTATE AURICULAR (OTIC) OIL 110270 0RE8K4LNJS 3.85%v/v
ISOPROPYL MYRISTATE AURICULAR (OTIC) SUSPENSION 110270 0RE8K4LNJS 0.02%w/w
ISOPROPYL MYRISTATE TOPICAL AEROSOL 110270 0RE8K4LNJS 9.3%w/w
ISOPROPYL MYRISTATE TOPICAL AEROSOL, FOAM 110270 0RE8K4LNJS 7.9%w/w
ISOPROPYL MYRISTATE TOPICAL AEROSOL, SPRAY 110270 0RE8K4LNJS 6.89%w/w
ISOPROPYL MYRISTATE TOPICAL CREAM 110270 0RE8K4LNJS 43mg
ISOPROPYL MYRISTATE TOPICAL CREAM, AUGMENTED 110270 0RE8K4LNJS 8%w/w
ISOPROPYL MYRISTATE TOPICAL GEL 110270 0RE8K4LNJS 10%w/w
ISOPROPYL MYRISTATE TOPICAL LOTION 110270 0RE8K4LNJS 5%w/w
ISOPROPYL MYRISTATE TOPICAL OIL 110270 0RE8K4LNJS 182mg
ISOPROPYL MYRISTATE TOPICAL OINTMENT 110270 0RE8K4LNJS 35%w/w
ISOPROPYL MYRISTATE TOPICAL SPRAY 110270 0RE8K4LNJS 41.3%w/v
ISOPROPYL MYRISTATE TOPICAL SYSTEM 110270 0RE8K4LNJS 7mg
ISOPROPYL MYRISTATE TRANSDERMAL FILM 110270 0RE8K4LNJS 58.08mg
ISOPROPYL MYRISTATE TRANSDERMAL FILM, EXTENDED RELEASE 110270 0RE8K4LNJS 20.4mg
ISOPROPYL MYRISTATE TRANSDERMAL GEL 110270 0RE8K4LNJS 50mg
ISOPROPYL MYRISTATE TRANSDERMAL GEL, METERED 110270 0RE8K4LNJS 1%w/w
ISOPROPYL MYRISTATE TRANSDERMAL SYSTEM 110270 0RE8K4LNJS 7.25mg
ISOPROPYL MYRISTATE VAGINAL CREAM 110270 0RE8K4LNJS 1%w/w
ISOPROPYL MYRISTATE VAGINAL SUPPOSITORY 110270 0RE8K4LNJS 0.01mg
ISOPROPYL PALMITATE TOPICAL AEROSOL 142916 8CRQ2TH63M 7.3%w/w
ISOPROPYL PALMITATE TOPICAL AEROSOL, SPRAY 142916 8CRQ2TH63M 7.3%w/w
ISOPROPYL PALMITATE TOPICAL CREAM 142916 8CRQ2TH63M 32mg Y
ISOPROPYL PALMITATE TOPICAL CREAM, AUGMENTED 142916 8CRQ2TH63M 4%w/w
ISOPROPYL PALMITATE TOPICAL GEL 142916 8CRQ2TH63M NA
ISOPROPYL PALMITATE TOPICAL LOTION 142916 8CRQ2TH63M 5%w/w
ISOPROPYL PALMITATE TOPICAL OINTMENT 142916 8CRQ2TH63M NA
ISOPROPYL PALMITATE TOPICAL SPRAY 142916 8CRQ2TH63M 7.3%w/w
ISOPROPYL PALMITATE TRANSDERMAL FILM 142916 8CRQ2TH63M 2mg
ISOPROPYL PALMITATE TRANSDERMAL FILM, EXTENDED RELEASE 142916 8CRQ2TH63M 187.5mg
ISOSTEARIC ACID TOPICAL CREAM 30399849 X33R8U0062 25%w/w
ISOSTEARIC ACID TOPICAL GEL 30399849 X33R8U0062 0.2%w/w
ISOSTEARIC ACID TOPICAL OINTMENT 30399849 X33R8U0062 NA
ISOSTEARYL ALCOHOL TOPICAL CREAM 27458931 Q613OCQ44Y 3%w/w
ISOSTEARYL ALCOHOL TOPICAL LOTION 27458931 Q613OCQ44Y 100mg
ISOSTEARYL ALCOHOL TOPICAL OINTMENT 27458931 Q613OCQ44Y NA
ISOSTEARYL ALCOHOL TOPICAL SUSPENSION 27458931 Q613OCQ44Y 2.5%w/w
ISOTONIC SODIUM CHLORIDE SOLUTION EPIDURAL INJECTION, SUSPENSION, LIPOSOMAL VR5Y7PDT5W 0.57%w/v
ISOTONIC SODIUM CHLORIDE SOLUTION INTRAMUSCULAR INJECTION VR5Y7PDT5W 0.6%w/v
ISOTONIC SODIUM CHLORIDE SOLUTION INTRAVENOUS INJECTION VR5Y7PDT5W 0.9%w/v
ISOTONIC SODIUM CHLORIDE SOLUTION INTRAVENOUS SOLUTION VR5Y7PDT5W 1800mg

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English